LILLIAM VILLALOBOS

Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Psychiatry PHOENIX, AZ NPI 1437217007

General Payments — all program years on this page

$3,803.53

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 220
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $459.32 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $459.3220

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $499.4228
2019 $699.1345
2020 $313.6716
2021 $490.1028
2022 $621.0435
2023 $720.8548
2024 $459.3220

Records — PY2024 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1077914653 Janssen Pharmaceuticals, Inc $24.70 05/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1077915383 Janssen Pharmaceuticals, Inc $28.26 10/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1077915897 Janssen Pharmaceuticals, Inc $30.73 05/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1119000205 Otsuka America Pharmaceutical, Inc. $26.24 02/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1119000207 Otsuka America Pharmaceutical, Inc. $11.12 03/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1119000209 Otsuka America Pharmaceutical, Inc. $1.32 04/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1119000211 Otsuka America Pharmaceutical, Inc. $18.73 04/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1119000213 Otsuka America Pharmaceutical, Inc. $27.25 08/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1119000215 Otsuka America Pharmaceutical, Inc. $27.15 09/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1119000217 Otsuka America Pharmaceutical, Inc. $26.31 12/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120614728 Alkermes, Inc. $23.26 05/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120614730 Alkermes, Inc. $18.51 06/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120614732 Alkermes, Inc. $25.37 08/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144540059 Indivior Inc. $28.05 03/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150833358 Neurocrine Biosciences, Inc. $27.14 02/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150840752 Neurocrine Biosciences, Inc. $24.71 06/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151462642 Teva Pharmaceuticals USA, Inc. $22.41 01/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151462706 Teva Pharmaceuticals USA, Inc. $32.31 04/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151462750 Teva Pharmaceuticals USA, Inc. $16.58 07/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151462788 Teva Pharmaceuticals USA, Inc. $19.17 12/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.